Mylab’s innovative solutions to End TB involves faster, more accurate, and cost-effective TB detection, latent TB screening and Prevention.
*0 Million
People were suffering from TB worldwide in 2023.
*0%
Of global TB cases in 2023 are from India.
*0 Million
Lives saved by TB diagnosis and treatment
*0 Million
Deaths were caused by TB in 2023 globally.
About Program
Tuberculosis (TB) remains a global challenge, and The WHO emphasizes the need for robust, high-quality systems with modern diagnostics for rapid and accurate TB detection. Mylab’s End TB Program addresses this urgency with a comprehensive, end-to-end solution—accelerating screening, and diagnosis. Committed to eliminating TB, Mylab empowers healthcare systems with cutting-edge technology to detect, manage, and prevent the disease, bringing us closer to a TB-free world.
Screening
TB screening detects latent and active infections early, enabling timely treatment, reducing transmission, and preventing complications. It is vital for high-risk populations and essential for global TB control.
Cy-Tb™
Cy-Tb is the next-generation test for latent TB detection.
Advanced diagnostics, like Mylab’s molecular assays, enable reliable, accurate, and drug-resistant TB identification, ensuring early treatment and better disease control.
PathoDetect®
The Pathogen Detection Expert Detect infectious pathogens with ease.
The government lays standardized treatment regimen for MDR TB in India. Strict adherence to medication is crucial to prevent resistance and ensure cure.
MyVan® is Mylab’s mobile testing laboratory enabling faster diagnostic tests; on the go. MyVan®, is accredited by NABL certification. It is also validated and approved by the ICMR and the NIV.